Evidence map›Paper›PMID 37624278›Full record

ReviewVeterinary sciences2023

Research Progress on the Development of Porcine Reproductive and Respiratory Syndrome Vaccines.

Hang Zhang, Qin Luo, Yingxin He, Yajie Zheng, Huiyang Sha, Gan Li, Weili Kong, Jiedan Liao, Mengmeng Zhao

Open access · goldAbstract readReview
In one paragraph

Review in Veterinary sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Hang ZhangSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Qin LuoSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Yingxin HeSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Yajie ZhengSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Huiyang ShaSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Gan LiSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Weili KongGladstone Institutes of Virology and Immunology, University of California, San Francisco, CA 94158, USA.ORCID 0000-0002-9104-7730
Jiedan LiaoSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.
Mengmeng ZhaoSchool of Life Science and Engineering, Foshan University, Foshan 528000, China.ORCID 0000-0003-4143-3606
Foshan University · CNGladstone Institutes · US

Funding

National Natural Science Foundation of China 31902279
6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome (PRRS) is a highly contagious disease in the pig industry, but its pathogenesis is not yet fully understood. The disease is caused by the PRRS virus (PRRSV), which primarily infects porcine alveolar macrophages and disrupts the immune system. Unfortunately, there is no specific drug to cure PRRS, so vaccination is crucial for controlling the disease. There are various types of single and combined vaccines available, including live, inactivated, subunit, DNA, and vector vaccines. Among them, live vaccines provide better protection, but cross-protection is weak. Inactivated vaccines are safe but have poor immune efficacy. Subunit vaccines can be used in the third trimester of pregnancy, and DNA vaccines can enhance the protective effect of live vaccines. However, vector vaccines only confer partial protection and have not been widely used in practice. A PRRS vaccine that meets new-generation international standards is still needed. This manuscript provides a comprehensive review of the advantages, disadvantages, and applicability of live-attenuated, inactivated, subunit, live vector, DNA, gene-deletion, synthetic peptide, virus-like particle, and other types of vaccines for the prevention and control of PRRS. The aim is to provide a theoretical basis for vaccine research and development.

Indexed as

advantages and disadvantagesapplicabilityporcine reproductive and respiratory syndromeresearch progressvaccine

Identifiers

PMID37624278
PMCPMC10459618
OpenAlexW4385423842

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.